title: Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome.
abstract: OBJECTIVE
  Gestational diabetes mellitus (GDM) is associated with adverse maternal and fetal outcome. Screening for GDM is therefore recommended but the best screening method remains controversial. This prospective, randomized study compared a risk factor-based screening programme with a universally based one.
  
  
  METHODS
  Subjects were randomized at booking to one of two groups: the risk factor group had a 3-h 100-g oral glucose tolerance test (OGTT) at 32 weeks if any risk factor for GDM was present; the universal group had a 50-g glucose challenge test performed and if their plasma glucose at 1 h was > or = 7.8 mmol/l, a formal 3-h 100-g OGTT was then performed.
  
  
  RESULTS
  Universal screening detected a prevalence of GDM of 2.7%, significantly more than the 1.45% detected in the risk factor screened group (P<0.03). Universal screening facilitated earlier diagnosis than risk factor screening - mean gestation 30 +/- 2.6 weeks vs. 33 +/- 3.7 weeks (P<0.05). A higher rate of spontaneous vaginal delivery at term, and lower rates of macrosomia, Caesarean section, prematurity, pre-eclampsia and admission to neonatal intensive care unit were observed in the universally screened, early diagnosis group.
  
  
  CONCLUSIONS
  Universal screening for GDM is superior to risk factor based screening-detecting more cases, facilitating early diagnosis and is associated with improved pregnancy outcome.
authors.affiliation: Department of Diabetes and Endocrinology, Mater Misericordiae Hospital, Dublin, Ireland.
authors.forename: M E
authors.initials: ME
authors.lastname: Griffin
authors.forename: M
authors.initials: M
authors.lastname: Coffey
authors.forename: H
authors.initials: H
authors.lastname: Johnson
authors.forename: P
authors.initials: P
authors.lastname: Scanlon
authors.forename: M
authors.initials: M
authors.lastname: Foley
authors.forename: J
authors.initials: J
authors.lastname: Stronge
authors.forename: N M
authors.initials: NM
authors.lastname: O'Meara
authors.forename: R G
authors.initials: RG
authors.lastname: Firth
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D002585:Cesarean Section / Q000706:statistics & numerical data; D036861:Delivery, Obstetric; D016640:Diabetes, Gestational / Q000175:diagnosis* / Q000453:epidemiology; D005260:Female; D005320:Fetal Macrosomia / Q000453:epidemiology; D005951:Glucose Tolerance Test; D006801:Humans; D006932:Hyperbilirubinemia / Q000453:epidemiology; D007003:Hypoglycemia / Q000453:epidemiology; D007231:Infant, Newborn; D007234:Infant, Premature; D007363:Intensive Care Units, Neonatal / Q000706:statistics & numerical data; D007494:Ireland / Q000453:epidemiology; D008403:Mass Screening / Q000379:methods*; D011225:Pre-Eclampsia / Q000453:epidemiology; D011247:Pregnancy; D011256:Pregnancy Outcome; D015995:Prevalence; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D001786:Blood Glucose